REMI (Remedent) Other Stockholders Equity: $0.10 Mil (As of Dec. 2020)


REMI Remedent Inc REMI
12 GF Score
Price $0.00
View Full Analysis

What is Remedent Other Stockholders Equity?

Remedent REMI +16.67% 12 Other Stockholders Equity is $0.10 Mil as of Dec. 2020. GuruFocus rates REMI with a GF Score™ of 12/100.

Remedent's Other Stockholders Equity for the quarter that ended in Dec. 2020 was $0.10 Mil.

Remedent's quarterly Other Stockholders Equity declined from Jun. 2020 ($0.10 Mil) to Sep. 2020 ($0.10 Mil) but then increased from Sep. 2020 ($0.10 Mil) to Dec. 2020 ($0.10 Mil).

Remedent's annual Other Stockholders Equity declined from Mar. 2018 ($0.10 Mil) to Mar. 2019 ($0.10 Mil) but then stayed the same from Mar. 2019 ($0.10 Mil) to Mar. 2020 ($0.10 Mil).

Remedent Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Remedent's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Remedent Other Stockholders Equity Chart

Remedent Annual Data
Trend Mar11 Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.10 0.10 0.10 0.10 0.10

Remedent Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.10 0.10 0.10 0.10 0.10
REMI
12GF Score
Remedent Inc REMI
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Remedent Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $0.10 Mil mean?
Remedent (REMI) has a Other Stockholders Equity of $0.10 Mil as of Dec. 2020. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Remedent and its competitors.
Is Remedent's Other Stockholders Equity too high?
Remedent's current Other Stockholders Equity is $0.10 Mil. Overall, Remedent has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Remedent's Other Stockholders Equity compare to SECI and RSCF?
Remedent's Other Stockholders Equity of $0.10 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Devices & Instruments company?
A good Other Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Remedent and its competitors. Remedent's current Other Stockholders Equity is $0.10 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Remedent stock overvalued right now?
Remedent (REMI) has a current Other Stockholders Equity of $0.10 Mil. The current Other Stockholders Equity is $0.10 Mil. Remedent's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Remedent (REMI), the current Other Stockholders Equity is $0.10 Mil as of Dec. 2020. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Remedent Business Description

Address Zuiderlaan 1-3, Bus 8, Ghent, BEL, 9000
Remedent Inc is a manufacturer of cosmetic dentistry products in Europe. The company is engaged in the research, development, and manufacturing of oral care and cosmetic dentistry products. It designs, develops, manufactures, and distributes cosmetic dentistry products, including a full line of professional dental products that are distributed in Europe, Asia, the Middle East, and the United States.
12GF Score

Get the complete analysis for REMI

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price